Umlobi: Gregory Harris
Usuku Lokudalwa: 10 Epreli 2021
Ukuvuselela Usuku: 18 Unovemba 2024
Anonim
L-Триптофан и 5-HTP что это? Как принимать от депрессии, бессонницы и для похудения?
Ividiyo: L-Триптофан и 5-HTP что это? Как принимать от депрессии, бессонницы и для похудения?

-Delile

I-5-HTP (5-hydroxytryptophan) ingumkhiqizo wamakhemikhali owakhiwe ngebhulokhi L-tryptophan. Iphinde ikhiqizwe ngokuhweba kusuka enzalweni yesitshalo sase-Afrika esaziwa ngeGriffonia simplicifolia.

I-5-HTP isetshenziselwa ukuphazamiseka kokulala njengokuqwasha, ukucindezeleka, ukukhathazeka nezinye izimo eziningi, kodwa abukho ubufakazi obuhle besayensi obusekela iningi lalokhu kusetshenziswa.

Imibhalo Yemvelo Yemininingwane Ephelele ukukala ukusebenza ngokuncike ebufakazini besayensi ngokwesilinganiso esilandelayo: Okusebenzayo, Okungenzeka Kusebenze, Okungenzeka Kusebenze, Okungenzeka Kungasebenzi, Cishe Okungaphumeleli, Ukungasebenzi, Nobufakazi Obunganele Bokulinganisa.

Izilinganiso zokusebenza ze 5-HTP zimi kanje:

Kungenzeka kusebenze ...

  • Ukucindezeleka. Ukuthatha i-5-HTP ngomlomo kubonakala kuthuthukisa izimpawu zokucindezeleka kwabanye abantu. Olunye ucwaningo lomtholampilo lukhombisa ukuthi ukuthatha i-5-HTP ngomlomo kungahle kuzuzise njengemithi ethile elwa nodokotela yokuthuthukisa izimpawu zokucindezeleka. Ezifundweni eziningi, kwathathwa i-150-800 mg nsuku zonke ye-5-HTP. Kwezinye izimo, amanani aphezulu asetshenzisiwe.

Kungenzeka kungasebenzi ku ...

  • I-Down syndrome. Olunye ucwaningo lubonisa ukuthi ukunikeza i-5-HTP ezinganeni ezine-Down syndrome kungathuthukisa imisipha nomsebenzi. Olunye ucwaningo lukhombisa ukuthi ayithuthukisi imisipha noma ukukhula lapho ithathwa kusukela ebuntwaneni kuze kube yiminyaka engu-3-4. Ucwaningo lukhombisa nokuthi ukuthatha i-5-HTP kanye nemithi ejwayelekile kadokotela kuthuthukisa intuthuko, amakhono ezenhlalo, noma amakhono olimi.

Ubufakazi obanele bokukala ukusebenza kwe ...

  • Uhlobo lokukhathazeka olumakwe yimicabango ephindaphindwayo nokuziphatha okuphindaphindwayo (ukukhathazeka ngokweqile noma i-OCD). Ucwaningo lokuqala lubonisa ukuthi ukuthatha i-5-HTP ne-antidepressant drug fluoxetine (Prozac) amasonto ayi-12 kungathuthukisa ezinye izimpawu ze-OCD.
  • Ukuphazamiseka kokusebenzisa utshwala. Ucwaningo lwakuqala lukhombisa ukuthi ukuthatha i-5-HTP nge-D-phenylalanine ne-L-glutamine izinsuku ezingama-40 kunganciphisa izimpawu zokuhoxa utshwala. Kodwa-ke, ukuthatha i-5-HTP nge-carbidopa nsuku zonke unyaka owodwa akubonakali kusiza abantu bayeke ukuphuza. Umphumela we-5-HTP kuphela ekuphuzeni ngokweqile awucaci.
  • Isifo i-Alzheimer. Ucwaningo lwakuqala luphakamisa ukuthi ukuthatha i-5-HTP ngomlomo akusizi izimpawu zesifo i-Alzheimer.
  • Ukukhathazeka. Ubufakazi ngemiphumela ye-5-HTP yokukhathazeka abucaci. Ucwaningo lwakuqala lukhombisa ukuthi ukuthatha i-25-150 mg ye-5-HTP ngomlomo nsuku zonke kanye ne-carbidopa kubonakala kunciphisa izimpawu zokukhathazeka kubantu abanezinkinga zokukhathazeka. Kodwa-ke, olunye ucwaningo lwakuqala lukhombisa ukuthi ukuthatha imithamo ephezulu ye-5-HTP, 225 mg nsuku zonke noma ngaphezulu, kubonakala kwenza ukukhathazeka kube kubi kakhulu. Futhi, ukuthatha ama-60 mg we-5-HTP nsuku zonke ngomthambo akukunciphisi ukukhathazeka kubantu abanezinkinga zokwethuka.
  • Ukulimala kobuchopho okuthinta ukunyakaza kwemisipha (i-cerebellar ataxia). Ubufakazi bokusetshenziswa kwe-5-HTP ye-cerebellar ataxia abucaci. Ubufakazi bokuqala bukhombisa ukuthi ukuthatha u-5 mg / kg we-5-HTP nsuku zonke izinyanga ze-4 kunganciphisa ukungasebenzi kwesistimu yezinzwa. Kodwa-ke, olunye ucwaningo lukhombisa ukuthi ukuthatha i-5-HTP nsuku zonke kuze kube unyaka owodwa akuzithuthukisi izimpawu ze-cerebellar ataxia.
  • I-Fibromyalgia. Ucwaningo lwakuqala luphakamisa ukuthi ukuthatha i-100 mg ye-5-HTP ngomlomo kathathu nsuku zonke izinsuku ezingama-30-90 kungathuthukisa ubuhlungu, ubumnene, ukulala, ukukhathazeka, ukukhathala, nokuqina kwasekuseni kubantu abane-fibromyalgia.
  • Izimpawu zokunqamuka kokuya esikhathini. Ucwaningo lokuqala lubonisa ukuthi ukuthatha i-150 mg ye-5-HTP nsuku zonke amasonto ama-4 akukunciphisi ukukhanya okushisayo kwabesifazane be-postmenopausal.
  • Migraine. Ubufakazi bemiphumela ye-5-HTP yokuvikela noma yokwelapha i-migraines kubantu abadala abucaci. Olunye ucwaningo lukhombisa ukuthi ukuthatha i-5-HTP nsuku zonke akukunciphisi i-migraines, kanti ezinye izifundo zikhombisa ukuthi kungazuzisa njengemithi kadokotela. I-5-HTP ayibonakali inciphisa imigraines ezinganeni.
  • Ukukhuluphala ngokweqile. Ucwaningo lwakuqala luphakamisa ukuthi ukuthatha i-5-HTP kungasiza ekunciphiseni ukudla, ukudla okunekhalori, kanye nesisindo kubantu abakhuluphele ngokweqile. Olunye ucwaningo luphakamisa ukuthi ukusebenzisa isifutho somlomo esithile esiqukethe i-5-HTP nezinye izinto ezikhishwayo (i-5-HTP-Nat Exts, iMedestea Biotech S.p.a., iTorino, e-Italy) amasonto ama-4 kwandisa ukwehla kwesisindo cishe ngama-41% kwabesifazane abakhuluphele ngokweqile be-postmenopausal.
  • Ukuhoxa kwi-heroin, morphine, nezinye izidakamizwa ze-opioid. Ucwaningo lwasekuqaleni luphakamisa ukuthi ukuthatha ama-200 mg we-5-HTP nsuku zonke izinsuku ezingama-6 kanye ne-tyrosine, i-phosphatidylcholine, ne-L-glutamine, kungahle kunciphise ukuqwasha nezimpawu zokuhoxa ekutholeni imilutha ye-heroin.
  • Isifo se-Parkinson. Ucwaningo lwakuqala lukhombisa ukuthi ukuthatha i-100-150 mg ye-5-HTP ngomlomo nsuku zonke ngemithi ejwayelekile kubonakala kunciphisa ukuzamazama, kepha lezi zinzuzo ziqhubeka kuphela izinyanga ezifika kwezingu-5. Olunye ucwaningo lokuqala lukhombisa ukuthi ukuthatha ama-50 mg we-5-HTP nsuku zonke kunganciphisa izimpawu zokuphazamiseka kokunyakaza kusuka ku-levodopa yezidakamizwa, kanye nezimpawu zokucindezeleka, kubantu abanesifo i-Parkinson. Kepha ukuthatha imithamo emikhulu ye-5-HTP, 275-1500 mg nsuku zonke, kanye ne-carbidopa kungazenza zibe zimbi izimpawu ezithile.
  • Ikhanda lokucindezeleka. Ucwaningo lwakuqala luphakamisa ukuthi ukuthatha i-100 mg ye-5-HTP kathathu nsuku zonke emavikini ayisishiyagalombili akubunciphisi ubuhlungu noma ubude bezinhlungu zekhanda.
  • Ukunakwa kokushoda-i-hyperactivity disorder (ADHD).
  • Ukuqwasha.
  • Isifo se-premenstrual dysphoric (PMDD).
  • I-Premenstrual syndrome (i-PMS).
  • Isifo se-Ramsey-Hunt.
  • Ezinye izimo.
Kudingeka ubufakazi obuningi ukukala ukusebenza kwe-5-HTP yalokhu kusetshenziswa.

I-5-HTP isebenza ebuchosheni nasesimisweni sezinzwa eziphakathi ngokwandisa ukukhiqizwa kwe-serotonin yamakhemikhali. I-Serotonin ingathinta ukulala, isifiso sokudla, izinga lokushisa, ukuziphatha ngokocansi nokuzwa ubuhlungu. Njengoba i-5-HTP inyusa ukuhlanganiswa kwe-serotonin, isetshenziselwa izifo eziningana lapho i-serotonin ikholelwa ukuthi idlala indima ebalulekile kubandakanya ukucindezeleka, ukuqwasha, ukukhuluphala, nezinye izimo eziningi.

Lapho ithathwa ngomlomo: 5-HTP kuyinto OKUNGENZEKA UKUPHEPHA lapho uthatha ngomlomo ngokufanele. Isetshenziswe ngokuphepha ngemithamo efinyelela ku-400 mg nsuku zonke kuze kube unyaka owodwa. Kodwa abanye abantu abathathe i-5-HTP bahlakulele isimo esibizwa nge-eosinophilia-myalgia syndrome (EMS). I-EMS yisimo esibi kakhulu esifaka ubuthakathaka obukhulu bemisipha (myalgia) nokungajwayelekile kwegazi (i-eosinophilia). Abanye abantu bacabanga ukuthi i-EMS ingahle idalwe isithako sengozi noma ukungcola kweminye imikhiqizo ye-5-HTP. Kodwa abukho ubufakazi obanele besayensi ukwazi ukuthi i-EMS ibangelwa yi-5-HTP, ukungcola, noma esinye isici. Kuze kube kwaziwa okuningi, i-5-HTP kufanele isetshenziswe ngokuqapha.

Eminye imiphumela emibi engaba khona ye-5-HTP ifaka isilungulela, ubuhlungu besisu, isicanucanu, ukuhlanza, isifo sohudo, ukozela, izinkinga zocansi nezinkinga zemisipha.

5-HTP kuyinto MHLAWUMBI ANGIPHEPHILE lapho ithathwa ngomlomo ngemithamo emikhulu. Imithamo evela ku-6-10 amagremu nsuku zonke ixhunyaniswe nezinkinga ezinzima zesisu kanye nokuqaqamba kwemisipha.

Ukuqapha okukhethekile nezixwayiso:

Ukukhulelwa nokuncelisa ibele: Alukho ulwazi olwanele olunokwethenjelwa ukwazi ukuthi i-5-HTP iphephile yini ukusetshenziswa lapho ukhulelwe noma uncelisa ibele. Hlala ohlangothini oluphephile futhi ugweme ukusetshenziswa.

Izingane: 5-HTP kuyinto OKUNGENZEKA UKUPHEPHA lapho ithathwa ngomlomo ngokufanele. Imithamo efinyelela ku-5 mg / kg nsuku zonke isetshenziswe ngokuphepha kuze kube yiminyaka emi-3 ezinganeni nasezinganeni ezineminyaka engama-12 ubudala. Njengabantu abadala, kukhona nokukhathazeka mayelana namandla e-eosinophilia-myalgia syndrome (EMS) ezinganeni, isimo esibi esibandakanya ubuthakathaka obukhulu bemisipha (myalgia) kanye nokungajwayelekile kwegazi (i-eosinophilia).

Ukuhlinzwa: I-5-HTP ingathinta ikhemikhali yobuchopho ebizwa nge-serotonin. Eminye imishanguzo enikezwa ngesikhathi sokuhlinzwa ingathinta ne-serotonin. Ukuthatha i-5-HTP ngaphambi kokuhlinzwa kungadala i-serotonin eningi ebuchosheni futhi kungaholela emiphumeleni emibi ebandakanya izinkinga zenhliziyo, ukuqhaqhazela nokukhathazeka. Tshela iziguli ukuthi ziyeke ukuthatha i-5-HTP okungenani amasonto ama-2 ngaphambi kokuhlinzwa.

Okukhulu
Ungathathi le nhlanganisela.
Imithi yokudangala (MAOIs)
I-5-HTP inyusa ikhemikhali ebuchosheni ebizwa nge-serotonin. Eminye imishanguzo esetshenziselwa ukucindezelwa nayo inyusa i-serotonin. Ukuthatha i-5-HTP ngale mithi esetshenziselwa ukudangala kungakhuphula i-serotonin kakhulu. Lokhu kungadala imiphumela emibi kakhulu kubandakanya ikhanda elibuhlungu, izinkinga zenhliziyo, ukuqhaqhazela, ukudideka nokukhathazeka.

Eminye yale mithi esetshenziselwa ukucindezeleka ifaka phakathi i-phenelzine (Nardil), i-tranylcypromine (i-Parnate), neminye.
Maphakathi
Qaphela ngale nhlanganisela.
I-Carbidopa (Lodosyn)
I-5-HTP ingathinta ubuchopho. ICarbidopa (Lodosyn) nayo ingathinta ubuchopho. Ukuthatha i-5-HTP kanye ne-carbidopa kungakhuphula ubungozi bemiphumela emibi kakhulu kubandakanya inkulumo esheshayo, ukukhathazeka, ulaka nabanye.
Imithi yokudambisa (i-CNS depressants)
I-5-HTP ingadala ubuthongo nozela. Imithi ebanga ubuthongo ibizwa ngokuthi yimithi yokuthambisa. Ukuthatha i-5-HTP kanye nemithi yokwelapha kungadala ukulala kakhulu.

Eminye imishanguzo yokuthambisa ibandakanya i-clonazepam (iKlonopin), i-lorazepam (Ativan), i-phenobarbital (iDonnatal), i-zolpidem (i-Ambien), neminye.
Izidakamizwa zeSerotonergic
I-5-HTP ingakhuphula ikhemikhali ebuchosheni ebizwa nge-serotonin. Eminye imithi ibuye inyuse i-serotonin. Ukuthatha i-5-HTP kanye nale mithi kungakhuphula i-serotonin kakhulu. Lokhu kungadala imiphumela emibi kakhulu kubandakanya ikhanda elibuhlungu, izinkinga zenhliziyo, ukuqhaqhazela, ukudideka nokukhathazeka.

Eminye yale mithi ifaka i-fluoxetine (Prozac), i-paroxetine (i-Paxil), i-sertraline (i-Zoloft), i-amitriptyline (i-Elavil), i-clomipramine (i-Anafranil), i-imipramine (i-Tofranil), i-sumatriptan (Imitrex), i-zolmitriptan (i-Zomig), i-rizatriptan i-methadone (i-Dolophine), i-tramadol (i-Ultram), nezinye eziningi.
Amakhambi kanye nezithasiselo ezinezakhiwo zokuthambisa
I-5-HTP ingadala ukulala noma ukozela. Ukuyisebenzisa kanye namanye amakhambi nezithako ezinomphumela ofanayo kungadala ukulala okuningi. Amanye alawa makhambi nezithasiselo afaka i-calamus, i-poppy yaseCalifornia, i-catnip, i-hops, i-dogwood yaseJamaican, i-kava, iSt John's wort, i-skullcap, i-valerian, i-yerba mansa, nezinye.
Amakhambi nezengezo ezinezakhiwo ze-serotonergic
I-5-HTP inyusa ikhemikhali yobuchopho ebizwa nge-serotonin. Ukuthatha i-5-HTP kanye namanye amakhambi nezengezo ezandisa i-serotonin kungaholela kwi-serotonin eningi kakhulu futhi kudale imiphumela emibi kubandakanya izinkinga zenhliziyo, ukuqhaqhazela nokukhathazeka. Amanye amakhambi nezithako ezengeza amazinga e-serotonin afaka phakathi i-Hawaiian baby woodrose, i-L-tryptophan, i-S-adenosylmethionine (i-SAMe), ne-St.
Akukho ukuxhumana okwaziwayo nokudla.
Imithamo elandelayo ifundwe ocwaningweni lwesayensi: ABADALA

NGOMLOMO:
  • Yokudangala: Ngokuvamile, i-150-800 mg nsuku zonke ithathwa amasonto ama-2-6. Le mithamo kwesinye isikhathi ihlukaniswa futhi iphathwe njenge-50 mg iye ku-100 mg kathathu ngosuku. Kwesinye isikhathi umthamo uqala uphansi futhi ukhuphuke ngokuqinile njalo emavikini e-1-2 kuze kufinyelelwe umthamo ohlosiwe. Ngaphansi kokujwayelekile, kusetshenziswa imithamo ephezulu. Kwesinye isifundo, umthamo ukhuphuke ngokuqinile kuze kufike kumagremu ama-3 ngosuku.
2-Amino-3- (5-Hydroxy-1H-Indol-3-yl) Propanoic Acid, 5 Hydroxy-Tryptophan, 5 Hydroxy-Tryptophane, 5-Hydroxytryptophan, 5-Hydroxytryptophane, 5-Hydroxy L-Tryptophan, 5-Hydroxy L-Tryptophane, 5-Hydroxy Tryptophan, 5-L-Hydroxytryptophan, L-5 HTP, L-5-Hydroxytryptophan, L-5-Hydroxytryptophane, i-Oxitriptan.

Ukuze ufunde kabanzi ngokuthi le ndatshana ibhalwe kanjani, sicela ubheke ifayela le- Imibhalo Yemvelo Yemininingwane Ephelele indlela.


  1. UMeloni M, uPuligheddu M, uSanna F, et al. Ukusebenza nokuphepha kwe-5-Hydroxytryptophan ezinkingeni zezimoto ezibangelwa i-levodopa kwisifo sikaParkinson: Ukutholwa kokuqala. UJ Neurol Sci. 2020; 415: 116869. Buka okungaqondakali.
  2. U-Yousefzadeh F, Sahebolzamani E, Sadri A, et al. I-5-Hydroxytryptophan njengokwelashwa kwe-adjuvant ekwelapheni ukuphazamiseka okulingene kuya kokucindezela ngokweqile: isilingo esenziwe kabili esimpumputhe ngokulawulwa kwe-placebo. I-Int Clin Psychopharmacol. 2020; 35: 254-262. Buka okungaqondakali.
  3. Javelle F, Lampit A, Bloch W, Häussermann P, Johnson SL, Zimmer P. Imiphumela ye-5-hydroxytryptophan ezinhlotsheni ezihlukile zokucindezeleka: ukubuyekezwa okuhlelekile nokuhlaziywa kwemeta. Umsoco Rev 2020; 78: 77-88. Buka okungaqondakali.
  4. UMeloni M, uPuligheddu M, uCarta M, uCannas A, uFororilli M, uDefazio G. Ukusebenza nokuphepha kwe-5-hydroxytryptophan ekucindezelekeni nasekunganakwa kwesifo sikaParkinson: ukutholwa kokuqala. I-Eur J Neurol 2020; 27: 779-786. Buka okungaqondakali.
  5. U-Israelyan N, uDel Colle A, uLi Z, et al. Imiphumela yeSerotonin kanye neSlow-Release 5-Hydroxytryptophan ku-Gastrointestinal Motility ku-Mouse Model of Depression. I-Gastroenterology. 2019; 157: 507-521.e4. Buka okungaqondakali.
  6. UMichelson D, Ikhasi le-SW, uCasey R, et al. Isifo esihlobene ne-eosinophilia-myaligia syndrome esihambisana nokuchayeka ku-l-5-hydroxytryptophan. UJ Rheumatol 1994; 21: 2261-5. Buka okungaqondakali.
  7. ILemaire PA, i-Adosraku RK. Indlela ye-HPLC yokuhlolwa okuqondile kwesandulela se-serotonin, i-5-hydroxytrophan, ezimbewini zeGriffonia simplicifolia. I-Phytochem Anal 2002; 13: 333-7. Bheka okungajwayelekile.
  8. URondanelli M, Opizzi A, Faliva M, Bucci M, Perna S. Ubudlelwano phakathi kokumunca i-5-hydroxytryptophan ekudleni okuhlanganisiwe, ngokusebenzisa iGriffonia simplicifolia ekhishwe, nomphumela ekuzondleni kwabesifazane abakhuluphele ngokweqile ngemuva kokuphathwa ngomlomo ngomlomo. Yidla Ukungezwani Kesisindo 2012; 17: e22-8. Buka okungaqondakali.
  9. I-Pardo JV. IMania kulandela ukungezwa kwe-hydroxytryptophan ku-monoamine oxidase inhibitor. IGen Hosp Psychiatry 2012; 34: 102.e13-4.
  10. Chen Chen, Liu Y, He W, Wang H, Wang Z.Neurotransmitter-precursor-supplement intervention for detoxified heroin addicts. UJ Huazhong Univ Sci Technolog Med Sci 2012; 32: 422-7.
  11. UGendle MH, u-Young EL, uRomano AC. Imiphumela ye-5-hydroxytryptophan yomlomo emsebenzini wokuhlela ojwayelekile: ukuqonda ngokuhlangana okungenzeka kwe-dopamine / serotonin ebuchosheni bangaphambili. I-Hum Psychopharmacol 2013; 28: 270-3.
  12. Umhlangano weKomidi Elilulekayo le-US Food and Drug Administration Compounding Advisory Committee ngoJuni 17-18, 2015. Itholakala ku: www.fda.gov/downloads/advisorycommittee/committeemeetingmaterials/drugs/pharmacycompoundingadvisorycommittee/ucm455276.pdf (kufinyelelwe ku-8/21/15).
  13. Ukuphathwa Kwezokudla Nezidakamizwa zase-U.S. Ukuqokwa kanye nokuvunywa kwezidakamizwa zezintandane. Kutholakala ku: www.accessdata.fda.gov/scripts/opdlisting/oopd/index.cfm (kufinyelelwe ngomhla ka-8/20/2015).
  14. I-Das YT, Bagchi M, Bagchi D, Preuss HG. Ukuphepha kwe-5-hydroxy-L-tryptophan. I-Toxicol Lett 2004; 150: 111-22. Buka okungaqondakali.
  15. U-Weise P, uKoch R, uShaw KN, uRosenfeld MJ. Ukusetshenziswa kwe-5-HTP ekwelapheni i-Down's syndrome. Izifo zezingane 1974; 54165-8. Buka okungaqondakali.
  16. UBazelon M, uPaine RS, uCowie VA, et al. Ukuguqulwa kwe-hypotonia ezinganeni ezine-Down's syndrome ngokuphathwa kwe-5-hydroxytryptophan. ILancet 1967; 1: 1130-3. Buka okungaqondakali.
  17. Sano I. Ukwelashwa kokucindezeleka nge-L-5-hydroxytryptophan (L-5-HTP). I-Psychiatria et Neurologia Japonicas 1972; 74: 584.
  18. I-Klein P, i-Lees A, ne-Stern G. Imiphumela ye-5-hydroxytryptophan engapheli ekungazinzi kweparkinsonia kokuhamba nokulinganisela nakwezinye izifo zemizwa. U-Adv Neurol 1986; 45: 603-604.
  19. UVanPraag, H. M. noKorf, J. 5-Hydroxytryptophan njenge-antidepressant: Inani lokubikezela lokuhlolwa kwe-probenecid. I-Psychopharmacol. Inkunzi. Ngo-1972; 8: 34-35.
  20. I-Sicuteri F. 5-hydroxytryptophan ku-prophylaxis ye-migraine. Ukuxhumana Kwezocwaningo Lwezemithi 1972; 4: 213-218.
  21. URosano Burgio, F., Borgatti, R., Scarabello, E., noLanzi, G. Ukuphathwa yikhanda ezinganeni nasebusheni. Izinqubo ze-First International Symposium on Headache in Children and Adolecents. 1989; 339-47.
  22. I-Mathew NT. I-5-hydroxytryptophan ku-prophylaxis ye-migraine: isifundo esiphindwe kabili. Ubuhlungu bekhanda 1978; 18: 111.
  23. UDe Benedittis G, uMassei R. 5-HT abandulelayo ku-migraine prophylaxis: isifundo esiphambuka kabili esiyimpumputhe ne-L-5-hydroxytryptophan. Umtholampilo J Pain 1986; 2: 123-129.
  24. UWyatt, R. J., Vaughan, T., Kaplan, J., Galanter, M., noGreen, R. 5-Hydroxytryptophan kanye ne-schizophrenia engapheli. Ku: Barchas J no-Usdin E. Serotonin nokuziphatha. ENew York: I-Acedemic Press; 1973.
  25. UBrodie HKH, uSack R, kanye noSiever L. Ucwaningo lwezokwelapha lwe-L-5-hydroxytryptophan ekucindezelekeni. Ku: Barchas J no-Usdin E. Serotonin nokuziphatha. ENew York: I-Academic Press; 1973.
  26. I-Auffret, M., Comte, H., ne-Bene, J. Eosinophilia-myalgia syndrome eyenziwe yi-L-5 hydroxytryptophane: cishe amacala amathathu. I-Fund Clin Pharmacol 2013; Isuppl 1: iphosta P2-204.
  27. UCangiano C, uLaviano A, uDel Ben M, et al. Imiphumela ye-5-hydroxy-tryptophan yomlomo ekudleni kwamandla nokukhethwa kwe-macronutrient ezigulini zesifo sikashukela ezingancikile ku-insulin. I-Int J Obes Relat Metab Disord 1998; 22: 648-54. Buka okungaqondakali.
  28. UJu, C. Y. no Tsai, C. T. Serotonergic izindlela ezibandakanyeka ekucindezelweni kokondliwa yi-5-HTP kumagundane. UChin J Physiol 1995; 38: 235-240. Buka okungaqondakali.
  29. UPranzatelli, M. R., Tate, E., Galvan, I., no Wheeler, A. Isivivinyo esilawulwayo se-5-hydroxy-L-tryptophan ye-ataxia ku-myoclonus epilepsy eqhubekayo. Umtholampilo Neurol. 1996; 98: 161-164. Buka okungaqondakali.
  30. UFrith, C. D., Johnston, E. C., Joseph, M.H, Powell, R. J., noWatts, R. W. Isivivinyo somtholampilo esingaboni kabili se-5-hydroxytryptophan esimweni se-Lesch- Nyhan syndrome. J Neurol Neurosurg. Ukusebenza kwengqondo 1976; 39: 656-662. Buka okungaqondakali.
  31. Bastard, J., Truelle, J. L., no-Emile, J. [Ukusebenza kwe-5 hydroxy-tryptophan ku-Parkinson's disease]. UNouv Presse Med 9-11-1976; 5: 1836-1837. Buka okungaqondakali.
  32. UTrouillas P, uSerratrice G, uLaplane D, et al. Ifomu le-Levorotatory le-5-hydroxytryptophan ku-ataxia ka-Friedreich. Imiphumela yocwaningo lokubambisana lwezidakamizwa ezingaboni kahle. I-Arch Neurol 1995; 52: 456-60. Buka okungaqondakali.
  33. UWessel K, uHermsdörfer J, uDeger K, et al. Isifundo se-crossover esiyimpumputhe esinefomu levorotatory ye-hydroxytryptophan ezigulini ezinezifo ezikhubazekayo ze-cerebellar. I-Arch Neurol 1995; 52: 451-5. Buka okungaqondakali.
  34. U-Alino, J. J., Gutierrez, J. L., no-Iglesias, M. L. 5-Hydroxytryptophan (5-HTP) kanye ne-MAOI (nialamide) ekwelapheni ukudangala. Ucwaningo olulawulwa kabili. I-Int Pharmacopsychiatry 1976; 11: 8-15. Buka okungaqondakali.
  35. UPranzatelli, M. R., Tate, E., Huang, Y., Haas, R. H., Bodensteiner, J., Ashwal, S., noFranz, D. Neuropharmacology yesifo sokuwa se-myoclonus esiqhubekayo: impendulo ku-5- hydroxy-L-tryptophan. Isifo sokuwa 1995; 36: 783-791. Buka okungaqondakali.
  36. UThomson, J., Rankin, H., Ashcroft, GW, Yates, CM, McQueen, JK, noCummings, SW Ukwelashwa kokucindezeleka ekusebenzeni okujwayelekile: ukuqhathanisa i-L- tryptophan, i-amitriptyline, kanye nenhlanganisela ye-L-tryptophan kanye ne-amitriptyline nge-placebo. I-Psychol Med 1982; 12: 741-751. Buka okungaqondakali.
  37. UTrouillas, P., Garde, A., Robert, JM, Renaud, B., Adeleine, P., Bard, J., noBrudon, F. [Ukulungiswa kwe-cerebellar syndrome ngaphansi kokuphathwa kwesikhathi eside kwe-5-HTP noma inhlanganisela ye-5-HTP ne-benserazide. Amacala angama-26 alinganiswa futhi aphathwe kusetshenziswa izindlela zekhompyutha]. UMfu Neurol. (EParis) 1982; 138: 415-435. Buka okungaqondakali.
  38. Thal, L. J., Sharpless, N. S., Wolfson, L., noKatzman, R. Ukwelashwa kwe-myoclonus nge-L-5-hydroxytryptophan ne-carbidopa: ukubonwa kwemitholampilo, i-electrophysiological, ne-biochemical. U-Ann Neurol 1980; 7: 570-576. Buka okungaqondakali.
  39. van Hiele LJ. l-5-Hydroxytryptophan ekucindezelekeni: ukwelashwa kokuqala kokufaka esikhundleni sokwelashwa kwengqondo? Ukwelashwa kweziguli ezingama-99 ezingaphandle ezinezimpawu zokumelana nokwelashwa. I-Neuropsychobiology 1980; 6: 230-40. Buka okungaqondakali.
  40. Magnussen, mina.kanye noNielsen-Kudsk, F. Bioavailability kanye ne-pharmacokinetics ehlobene nayo kumuntu ophethwe ngomlomo i-L-5-hydroxytryptophan esimeni esizinzile. I-Acta Pharmacol Toxicol. (ICopenh) 1980; 46: 257-262. Buka okungaqondakali.
  41. UTrouillas, P., Garde, A., Robert, J. M., no-Adeleine, P. [Ukuhlehliswa kwe-cerebellar ataxia yomuntu ngaphansi kokuphathwa kwesikhathi eside kwe-5-hydroxytryptophan]. I-CR Izimo ze-Acad Sci III 1-5-1981; 292: 119-122. Buka okungaqondakali.
  42. UPueschel SM, uMhlanga RB, uCronk CE, uGoldstein BI. I-5-hydroxytryptophan ne-pyridoxine. Imiphumela yabo ezinganeni ezincane ezine-Down's syndrome. Ngingu-J Dis Child 1980; 134: 838-44. Buka okungaqondakali.
  43. Longo G, Rudoi I, Iannuccelli M, Strinati R, Panizon F. [Ukwelashwa kwekhanda elibalulekile eminyakeni yokukhula nge-L-5-HTP (uwele izifundo ezingaboni kabili uqhathanisa ne-placebo)]. I-Pediatr Med Chir 1984; 6: 241-5. Buka okungaqondakali.
  44. UBono, G., Micieli, G., Sances, G., Calvani, M., noNappi, G. L-5HTP ukwelashwa ezinhlokweni eziyinhloko: umzamo wokuhlonza imitholampilo yeziguli eziphendulayo. ICephalalgia 1984; 4: 159-165. Buka okungaqondakali.
  45. UQuadbeck, H., Lehmann, E., noTegeler, J. Ukuqhathanisa isenzo sokulwa nokucindezelwa kwe-tryptophan, inhlanganisela ye-tryptophan / 5- hydroxytryptophan kanye ne-nomifensine. I-Neuropsychobiology 1984; 11: 111-115. Buka okungaqondakali.
  46. van Praag, H. M. Ekufuneni indlela yokusebenza kwama-anti-depressants: izingxube ze-5-HTP / tyrosine ekucindezelekeni. U-Adv Biochem Psychopharmacol. 1984; 39: 301-314. Buka okungaqondakali.
  47. I-Trouillas P. Ukuhlehliswa kwe-cerebellar syndrome ngokuphathwa kwesikhathi eside kwe-5-HTP noma inhlanganisela ye-5-HTP-benserazide: amacala angama-21 anezimpawu ezilinganiselwe ezicutshungulwa yikhompyutha. Ital J Neurol Sci 1984; 5: 253-266. Buka okungaqondakali.
  48. van Praag, H. M. no de Haan, S. Chemoprophylaxis wokudangala. Umzamo wokuqhathanisa i-lithium ne-5- hydroxytryptophan. I-Acta Psychiatr.Scand Suppl 1981; 290: 191-201. Buka okungaqondakali.
  49. van Praag, H. no-de Hann, S. Ukuba sengozini kokucindezeleka kanye ne-5-hydroxytryptophan prophylaxis. I-Psychiatry Res. 1980; 3: 75-83. Buka okungaqondakali.
  50. Soulairac, A. [Isenzo se-Hypnotic se-mecloqualone. Ukuqhathanisa nemiphumela ye-placebo kanye ne-secobarbital]. Phakamisa iMed 4-10-1971; 79: 817-818. Buka okungaqondakali.
  51. Chase, T. N., Ng, L. K., noWatanabe, isifo sika-A.M. Parkinson. Ukuguqulwa ngu-5-hydroxytryptophan. I-Neurology 1972; 22: 479-484. Buka okungaqondakali.
  52. UWyatt, R. J., Vaughan, T., Galanter, M., Kaplan, J., noGreen, R. Izinguquko zokuziphatha kweziguli ezingama-schizophrenic ezingapheli ezinikezwe i-L-5- hydroxytryptophan. Isayensi 9-22-1972; 177: 1124-1126. Buka okungaqondakali.
  53. van Praag HM, Korf J, Dols LC, Schut T. Ucwaningo lomshayeli lwenani elibikezelayo lohlolo lwe-probenecid ekusetshenzisweni kwe-5-hydroxytryptophan njenge-antidepressant. I-Psychopharmacologia 1972; 25: 14-21. Buka okungaqondakali.
  54. UZarcone, V., Kales, A., Scharf, M., Tan, T. L., Simmons, J. Q., noDement, W. C. Ukuphindaphinda ngomlomo kwe-5-hydroxytryptophan. Umphumela kuzinqubo zokuziphatha nezokulala ezinganeni ezimbili ze-schizophrenic. I-Arch Gen Psychiatry 1973; 28: 843-846. Buka okungaqondakali.
  55. UChadwick, D., Hallett, M., Harris, R., Jenner, P., Reynolds, EH, noMarsden, CD Clinical, biochemical, kanye nezici zomzimba ezihlukanisa i-myoclonus ephendula i-5-hydroxytryptophan, i-tryptophan ene-monoamine oxidase inhibitor, futhi clonazepam. Ubuchopho 1977; 100: 455-487. Buka okungaqondakali.
  56. UVan Woert, M.H, Rosenbaum, D., Howieson, J., noBowers, M. B., Jr. Ukwelashwa kwesikhathi eside kwe-myoclonus nezinye izifo ze-neurologic ezine-L-5- hydroxytryptophan ne-carbidopa. N Engl J Med 1-13-1977; 296: 70-75. Buka okungaqondakali.
  57. UNolen WA, van de Putte JJ, Dijken WA, Kamp JS. I-L-5HTP ekucindezelekeni ukumelana nama-re-uptake inhibitors. Ucwaningo oluvulekile lokuqhathanisa ne-tranylcypromine. UBr J Psychiatry 1985; 147: 16-22. Buka okungaqondakali.
  58. UDe Benedittis G, uMassei R. Serotonin abandulelayo ekhanda eliyinhloko elingapheli. Isifundo esiphambuka esingaboni kabili esine-L-5-hydroxytryptophan vs. placebo. UJ Neurosurg Sci 1985; 29: 239-48. Buka okungaqondakali.
  59. UTitus F, Dávalos A, Alom J, Codina A. 5-Hydroxytryptophan kuqhathaniswa ne-methysergide ku-prophylaxis ye-migraine. Isivivinyo somtholampilo esingahleliwe. I-Eur Neurol 1986; 25: 327-9. Buka okungaqondakali.
  60. I-Santucci M, Cortelli P, Rossi PG, Baruzzi A, Sacquegna T. L-5-hydroxytryptophan kuqhathaniswa ne-placebo ebuntwaneni migraine prophylaxis: isifundo se-crossover esimpumputhe. UCephalalgia 1986; 6: 155-7. Buka okungaqondakali.
  61. U-Irwin, M. R., Marder, S. R., Fuentenebro, F., no-Yuwiler, A. L-5-hydroxytryptophan inciphisa izimpawu ezinhle zengqondo ezibangelwa yi-D-amphetamine. I-Psychiatry Res. 1987; 22: 283-289. Buka okungaqondakali.
  62. U-Angst J, Woggon B, Schoepf J. Ukwelashwa kokudangala nge-L-5-hydroxytryptophan kuqhathaniswa ne-imipramine. Imiphumela yezifundo ezimbili ezivulekile nezimpumputhe ezimbili. I-Arch Psychiatr Nervenkr 1977; 224: 175-86. Buka okungaqondakali.
  63. UKahn RS, Westenberg HG, Verhoeven WM, et al. Umphumela wesandulela se-serotonin kanye ne-uptake inhibitor ezinkingeni zokukhathazeka; ukuqhathanisa okungaboni kabili kwe-5-hydroxytryptophan, clomipramine ne-placebo. I-Int Clin Psychopharmacol 1987; 21: 33-45. Buka okungaqondakali.
  64. UDe Giorgis G, Miletto R, Iannuccelli M, Camuffo M, Scerni S. Headache ngokuhlangana nokuphazamiseka kokulala ezinganeni: ukuhlolwa kwe-psychodiagnostic nokulawulwa komtholampilo okulawulwayo - L-5-HTP kuqhathaniswa ne-placebo. Izidakamizwa Exp Clin Res 1987; 13: 425-33. Buka okungaqondakali.
  65. UZmilacher, K., Battegay, R., noGastpar, M. L-5-hydroxytryptophan kuphela futhi ngokuhlanganiswa ne-peripheral decarboxylase inhibitor ekwelapheni ukudangala. I-Neuropsychobiology 1988; 20: 28-35. Buka okungaqondakali.
  66. UNolen, W. A., van de Putte, J. J., Dijken, W. A., Kamp, J. S., Blansjaar, B. A., Kramer, H. J., noHaffmans, J. Isu lokwelapha ekucindezelekeni. II. Ama-MAO inhibitors ekucindezelekeni amelana ne-cyclic antidepressants: izifundo ezimbili ezilawulwayo ze-crossover ne-tranylcypromine kuqhathaniswa ne-L-5-hydroxytryptophan ne-nomifensine. I-Acta Psychiatr. Izwe 1988; 78: 676-683. Buka okungaqondakali.
  67. UKaneko M, Kumashiro H, Takahashi Y, Hoshino Y. L-5HTP ukwelashwa kanye nezinga le-serum 5-HT ngemuva kokulayisha kwe-L-5-HTP ezigulini ezicindezelekile. I-Neuropsychobiology 1979; 5: 232-40. Buka okungaqondakali.
  68. URousseau JJ. Imiphumela yenhlanganisela ye-levo-5-hydroxytryptophan-dihydroergocristine ekucindezelekeni nasekusebenzeni kwe-neuropsychic: isilingo somtholampilo esilawulwa kabili esingaboni kwiziguli esezikhulile. Umtholampilo Ther 1987; 9: 267-72. Buka okungaqondakali.
  69. U-Anders, T. F., Cann, H. M., Ciaranello, R. D., Barchas, J. D., noBerger, P. A. Ukubheka okunye ngokusetshenziswa kwe-5-hydroxytryptophan enganeni ene-Lesch-Nyhan syndrome. I-Neuropadiatrie. 1978; 9: 157-166. Buka okungaqondakali.
  70. UCeci F, uCangiano C, uCairella M, et al. Imiphumela yokuphathwa kwe-5-hydroxytryptophan ngomlomo ekuziphatheni kokudla ezifundweni zabantu abadala ezikhuluphele. UJ Neural Transm 1989; 76: 109-17. Buka okungaqondakali.
  71. UJangid P, Malik P, Singh P, Sharma M, Gulia AK. Ucwaningo lokuqhathanisa ukusebenza kwe-l-5-hydroxytryptophan ne-fluoxetine ezigulini ezethula ngesiqephu sokuqala sokucindezeleka. I-Asia J Psychiatr 2013; 6: 29-34. Buka okungaqondakali.
  72. UZarcone, V. P., Jr. noHoddes, E. Imiphumela ye-5-hydroxytryptophan ekwehlukaneni kwe-REM ukulala ezidakweni. NginguJ J Psychiatry 1975; 132: 74-76. Buka okungaqondakali.
  73. U-Opladen, T., Hoffmann, G. F., noBlau, N. Ucwaningo lwamazwe omhlaba lweziguli ezinokushoda kwe-tetrahydrobiopterin ezethula nge-hyperphenylalaninaemia. J Ifa. I-Metab Dis 2012; 35: 963-973. Buka okungaqondakali.
  74. I-Baraldi, S., Hepgul, N., Mondelli, V., ne-Pariante, C. M. Ukwelashwa okuyizimpawu zokucindezeleka okubangelwa i-interferon-alpha ku-hepatitis C: ukubuyekeza okuhlelekile. J Clin Psychopharmacol. 2012; 32: 531-543. Buka okungaqondakali.
  75. I-Pan, L., McKain, BW, Madan-Khetarpal, S., Mcguire, M., Diler, RS, Perel, JM, Vockley, J., kanye neBrent, DA GTP-cyclohydrolase ukuntuleka okuphendula i-sapropterin ne-5-HTP supplementation : ukukhululeka kokucindezeleka okwelashwa nokwelashwa kokuzibulala. Icala le-BMJ. 2011; 2011 Buka okungaqondakali.
  76. UFriedman, J., Roze, E., Abdenur, JE, Chang, R., Gasperini, S., Saletti, V., Wali, GM, Eiroa, H., Neville, B., Felice, A., Parascandalo, R., Zafeiriou, DI, Arrabal-Fernandez, L., Dill, P., Eichler, FS, Echenne, B., Gutierrez-Solana, LG, Hoffmann, GF, Hyland, K., Kusmierska, K., Tijssen, MA, Lutz, T., Mazzuca, M., Penzien, J., Poll-The BT, Sykut-Cegielska, J., Szymanska, K., Thony, B., noBlau, N. Sepiapterin reductase ukuntula: kuyelapheka ukulingisa ukukhubazeka kobuchopho. U-Ann Neurol. 2012; 71: 520-530. Buka okungaqondakali.
  77. UJukic T, Rojc B, Boben-Bardutzky D, Hafner M, Ihan A. Ukusetshenziswa kokufakwa kokudla nge-D-phenylalanine, L-glutamine kanye ne-L-5-hydroxytriptophan ekwehliseni izimpawu zokuhoxiswa kotshwala. IColl Antropol 2011; 35: 1225-30. Buka okungaqondakali.
  78. USarris, J. Ukucindezeleka kwemitholampilo: imodeli yokwelashwa ehlanganisayo esekwe ebufakazini. Ngenye indlela.I-Health Med. 2011; 17: 26-37. Buka okungaqondakali.
  79. UDill, P., Wagner, M., Somerville, A., Thony, B., Blau, N., noWeber, P. I-neurology yengane: ukuqina kwe-paroxysmal, ukubuka phezulu, ne-hypotonia: izimpawu zokushoda kwe-sepiapterin reductase. I-Neurology 1-31-2012; 78: e29-e32. Buka okungaqondakali.
  80. Horvath, GA, Selby, K., Poskitt, K., Hyland, K., Waters, PJ, Coulter-Mackie, M., noStockler-Ipsiroglu, SG Hemiplegic migraine, ukuquleka, i-spastic paraparesis eqhubekayo, ukuphazamiseka kwemizwelo, ne-coma ezinganeni zakubo ezine-serotonin ephansi ehlelekile. ICephalalgia 2011; 31: 1580-1586. Buka okungaqondakali.
  81. UMorrison, K. E. Ukulandelana kwe-genome ephelele kwazisa ukwelashwa: umuthi owenziwe waba ngowakho uthatha esinye isinyathelo sokuya phambili. Umtholampilo Chem 2011; 57: 1638-1640. Buka okungaqondakali.
  82. IBainbridge, MN, Wiszniewski, W., Murdock, DR, Friedman, J., Gonzaga-Jauregui, C., Newsham, I., Reid, JG, Fink, JK, Morgan, MB, Gingras, MC, Muzny, DM, IHoang, LD, Yousaf, S., Lupski, JR, kanye neGibbs, RA Ukulandelana kwe-genome-genome yokuphathwa kweziguli okwenziwe kahle. ISci Transl.Med 6-15-2011; 3: 87re3. Buka okungaqondakali.
  83. den Boer JA, Westenberg HG. Ukuziphatha, i-neuroendocrine, kanye nemiphumela ye-biochemical ye-5-hydroxytryptophan management in panic disorder. I-Psychiatry Res 1990; 31: 267-78. Buka okungaqondakali.
  84. I-Adamsen, D., Meili, D., Blau, N., Thony, B., neRamaekers, V. Autism ehlotshaniswa ne-5-hydroxyindolacetic acid ephansi ku-CSF kanye ne-heterozygous SLC6A4 gene Gly56Ala kanye ne-5-HTTLPR L / L eyahlukahluka yokukhuthaza . IMol.Genet.Metab 2011; 102: 368-373. Buka okungaqondakali.
  85. UCross, D. R., Kellermann, G., McKenzie, L. B., Purvis, K. B., Hill, G. J., noHuisman, H. Ukwelashwa kwe-amino acid okuhlosiwe okungahleliwe nezingane zokutholwa ezisengozini yokuziphatha. I-Dev Yezempilo Yezokunakekelwa Kwezingane. 2011; 37: 671-678. Buka okungaqondakali.
  86. UGendle, M. H. noGolding, A. C. Ukuphathwa ngomlomo kwe-5-hydroxytryptophan (5-HTP) kuphazamisa ukwenziwa kwezinqumo ngaphansi kokungacaci kodwa kungabi sengozini: ubufakazi obuvela e-Iowa Task Task. I-Hum Psychopharmacol. 2010; 25: 491-499. Buka okungaqondakali.
  87. U-Iovieno, N., Dalton, E. D., Fava, M., noMischoulon, D. Imithi elwa nezidambisi zemvelo ezinesigaba sesibili: ukubuyekeza nokuhlaziya. J Thinta Ukungezwani. 2011; 130: 343-357. Buka okungaqondakali.
  88. Leu-Semenescu, S., Arnulf, I., Decaix, C., Moussa, F., Clot, F., Boniol, C., Touitou, Y., Levy, R., Vidailhet, M., noReze, Imiphumela yokulala neyesigqi yokulahleka kofuzo okubangelwa i-serotonin. Ukulala 3-1-2010; 33: 307-314. Buka okungaqondakali.
  89. UFreedman RR. Ukwelashwa kokukhanya okushisayo kwe-menopausal nge-5-hydroxytryptophan. IMatritas 2010; 65: 383-5. Buka okungaqondakali.
  90. Amaviki, B. S. Ukwakheka kwezithako zokudla kanye nokukhishwa kwamakhambi okuphumula nokwenza isenzo sokukhathazeka: Isihlobo. IMed Sci Monit. U-2009; 15: RA256-RA262. Buka okungaqondakali.
  91. URondanelli M, uKlersy C, u-Iadarola P, et al. Iphrofayili yokusutha kanye ne-amino-acid kwabesifazane abakhuluphele ngokweqile ngemuva kokwelapha okusha kusetshenziswa isitshalo semvelo kukhipha ukwakhiwa kwesifafazi esingaphansi. I-Int J Obes (Lond) 2009; 33: 1174-1182. Buka okungaqondakali.
  92. IMaissen CP, iLudin HP. [Ukuqhathanisa umphumela we-5-hydroxytryptophan nepropranolol ekwelashweni kwesikhawu se-migraine]. USchweiz Med Wochenschr 1991; 121: 1585-90. Buka okungaqondakali.
  93. UShell W, uBullias D, uCharuvastra E, et al. Isivivinyo esilawulwa ngokungahleliwe, esilawulwa yi-placebo sokulungiselela i-amino acid ngesikhathi nekhwalithi yokulala. NginguJ Ther 2010; 17: 133-9. Buka okungaqondakali.
  94. UTrujillo-Martin, M. M., Serrano-Aguilar, P., Monton-Alvarez, F., noCarrillo-Fumero, R. Ukusebenza nokuphepha kwezindlela zokwelapha ama-ataxias okonakala: ukubuyekeza okuhlelekile. Ukuphazamiseka kweMov. 6-15-2009; 24: 1111-1124. Buka okungaqondakali.
  95. URothman, R. B. Ukwelashwa kokukhuluphala ngokweqile ngemithi yokwelapha "inhlanganisela". NginguJ Ther 2010; 17: 596-603. Buka okungaqondakali.
  96. Chae, HS, Kang, OH, Choi, JG, Oh, YC, Lee, YS, Jang, HJ, Kim, JH, Park, H., Jung, KY, Sohn, DH, and Kwon, DY 5-hydroxytryptophan enza ku i-mitogen-activated protein kinase extracellular-signal regated protein kinase pathway to modulate cyclooxygenase-2 and inducible nitric oxide synthase expression in RAW 264.7 cells. I-Biol Pharm Bull 2009; 32: 553-557. Buka okungaqondakali.
  97. UHendricks, E. J., Rothman, R. B., noGreenway, F. L. Ochwepheshe bezidudla odokotela bazisebenzisa kanjani izidakamizwa ukwelapha ukukhuluphala. Ukukhuluphala. (Isilivere.Spring) 2009; 17: 1730-1735. Buka okungaqondakali.
  98. I-Longo, N. Ukuphazamiseka kwe-biopterin metabolism. J Ifa. I-Metab Dis 2009; 32: 333-342. Buka okungaqondakali.
  99. Pons, R. I-phenotypic spectrum yezifo ze-neurotransmitter yezingane kanye neparkinsonism yezinsana. J Ifa. I-Metab Dis 2009; 32: 321-332. Buka okungaqondakali.
  100. Schaefer, M., Winterer, J., Sarkar, R., Uebelhack, R., Franke, L., Heinz, A., noFriebe, A. Amacala amathathu we-tryptophan add-on noma i-monotherapy ye-hepatitis C ne-IFNalpha Izinkinga zemizwa ezihlangene. I-Psychosomatics 2008; 49: 442-446. Buka okungaqondakali.
  101. UJacobsen, JP, Nielsen, EO, Hummel, R., Redrobe, JP, Mirza, N., noWeikop, P.Ukuzwela kwamagundane e-NMRI ekukhetheni ama-serotonin reuptake inhibitors akhethiwe esivivinyweni sokumiswa komsila kungaguqulwa ngokubambisana ne-5 -hydroxytryptophan. I-Psychopharmacology (Berl) 2008; 199: 137-150. Buka okungaqondakali.
  102. U-Liu, K. M., Liu, T. T., Lee, N. C., Cheng, L. Y., Hsiao, K. J., no-Niu, D. M. Ukulandelwa kwesikhathi eside kweziguli zase-Taiwan zase China belashwa kusenesikhathi ngenxa yokuntuleka kwe-6-pyruvoyl-tetrahydropterin synthase. I-Arch Neurol. 2008; 65: 387-392. Buka okungaqondakali.
  103. IHorvath, GA, Stockler-Ipsiroglu, SG, Salvarinova-Zivkovic, R., Lillquist, YP, Connolly, M., Hyland, K., Blau, N., Rupar, T., kanye namanzi, i-PJ Autosomal recessive GTP cyclohydrolase I ukuntuleka ngaphandle kwe-hyperphenylalaninemia: ubufakazi bokuqhubeka kwe-phenotypic phakathi kwamafomu amakhulu nacindezelayo. IMol.Genet.Metab 2008; 94: 127-131. Buka okungaqondakali.
  104. UMorrow, J. D., Vikraman, S., Imeri, L., no-Opp, M. R. Imiphumela yokwenza kusebenze kwe-serotonergic yi-5-hydroxytryptophan ekulaleni nasekushiseni komzimba kwe-C57BL / 6J kanye namagundane angenele e-interleukin-6-ahlobene nomthamo nesikhathi. Ukulala 1-1-2008; 31: 21-33. Buka okungaqondakali.
  105. Meolie, AL, Rosen, C., Kristo, D., Kohrman, M., Gooneratne, N., Aguillard, RN, Fayle, R., Troell, R., Townsend, D., Claman, D., Hoban, T., noMahowald, M. Ukwelashwa okungabhalwanga ngomlomo kokuqwasha: ukuhlolwa kwemikhiqizo enobufakazi obulinganiselwe. J Clin. Ukulala nge-4-15-2005; 1: 173-187. Buka okungaqondakali.
  106. UCangiano C, uCeci F, uCairella M, et al. Imiphumela ye-5-hydroxytryptophan ekuziphatheni kokudla nasekulandeleni imiyalo yokudla ezifundweni zabantu abadala abakhuluphele. U-Adv Exp Med Biol 1991; 294: 591-3. Buka okungaqondakali.
  107. UPetre-Quadens, O. noDe Lee, C. 5-Hydroxytryptophan futhi balale eDown's syndrome. UJ Neurol Sci 1975; 26: 443-453. Buka okungaqondakali.
  108. ULesch, K. P., Hoh, A., Disselkamp-Tietze, J., Wiesmann, M., Osterheider, M., noSchulte, H. M. 5-Hydroxytryptamine1A ukuphendula ngokwamukela ekuphazamisekeni okuphoqelela ngokweqile. Ukuqhathaniswa kweziguli nezilawuli. I-Arch Gen Psychiatry 1991; 48: 540-547. Buka okungaqondakali.
  109. IHalladay, i-AK, i-Wagner, i-GC, i-Sekowski, i-A, i-Rothman, i-RB, i-Baumann, i-MH, ne-Fisher, i-H.Ukuguqulwa kokuphuza utshwala, ukuxhashazwa kokuhoxiswa, nokudluliswa kwe-monoamine kumagundane aphathwe nge-phentermine ne-5-hydroxy-L-tryptophan . I-Synapse 2006; 59: 277-289. Buka okungaqondakali.
  110. UCurcio, J. J., Kim, L. S., Wollner, D., noPockaj, B. A. Amandla we-5-hydryoxytryptophan yokwehlisa i-flash hot: i-hypothesis. I-Altern Med Rev 2005; 10: 216-221. Buka okungaqondakali.
  111. UVictor, S. noRyan, S. W. Izidakamizwa zokuvimbela ukuphathwa yikhanda ezinganeni. Database leCochrane.Syst.Rev 2003; CD002761. Buka okungaqondakali.
  112. UGeorge DT, uLindquist T, uRawlings RR, et al. Ukulungiswa kwe-Pharmacologic yokuyeka iziguli ezinotshwala: akukho ukusebenza kwe-5-hydroxytryptophan noma i-levodopa. I-Clin Pharmacol Ther 1992; 52: 553-60. Buka okungaqondakali.
  113. UShaw, K., Turner, J., noDel Mar, C. Tryptophan kanye ne-5-hydroxytryptophan yokudangala. Idatha yedatha yeCochrane. ISyst Rev 2002; CD003198. Buka okungaqondakali.
  114. UCiaranello, R. D., Anders, T. F., Barchas, J. D., Berger, P. A., noCann, H. M. Ukusetshenziswa kwe-5-hydroxytryptophan enganeni ene-Lesch-Nyhan syndrome. Ingqondo Yezengqondo Yezingane Hum Dev 1976; 7: 127-133. Buka okungaqondakali.
  115. Anderson, L.T, Herrmann, L., noDancis, J. Umphumela we-L-5-hydroxytryptophan ku-self-mutilatin kulesifo seLesch-Nyhan: umbiko omubi. I-Neuropadiatrie. 1976; 7: 439-442. Buka okungaqondakali.
  116. Growdon, J. H., Young, R. R., no Shahani, B. T. L-5-hydroxytryptophan ekwelapheni ama-syndromes ahlukahlukene lapho i-myoclonus ivelele khona. I-Neurology 1976; 26: 1135-1140. Buka okungaqondakali.
  117. UTakahashi S, Kondo H, Kato N. Umphumela we-l-5-hydroxytryptophan ku-brain monoamine metabolism kanye nokuhlolwa komphumela wayo emitholampilo ezigulini ezicindezelekile. UJ Psychiatr Res 1975; 12: 177-87. Buka okungaqondakali.
  118. I-Preshaw RM, iLeavitt D, i-Hoag G. Isengezo sokudla i-5-hydroxytryptophan kanye ne-urinary 5-hydroxyindole acetic acid. I-CMAJ 2008; 178: 993. Buka okungaqondakali.
  119. Byerley WF, Judd LL, Reimherr FW, Grosser BI. I-5-Hydroxytryptophan: ukubuyekezwa kokusebenza kwayo okucindezelayo nemiphumela emibi. J Clin Psychopharmacol 1987; 7: 127-37 .. Buka okungaqondakali.
  120. UShaw K, Turner J, Del Mar C. Tryptophan kanye ne-5-hydroxytryptophan yokudangala. ICchrane Database Syst Rev 2002;: CD003198. Buka okungaqondakali.
  121. UCaruso I, uSarzi Puttini P, uCazzola M, u-Azzolini V. Ucwaningo oluphindwe kabili lwe-5-hydroxytryptophan kuqhathaniswa ne-placebo ekwelapheni i-fibromyalgia syndrome eyinhloko. UJ Int Med Res 1990; 18: 201-9. Buka okungaqondakali.
  122. UJohnson KL, uKlarskov K, uBenson LM, et al. Ukuba khona kwe-X ephezulu kanye nezinhlanganisela ezihlobene: ukungcola okubikiwe uma kwenzeka kuhlobene ne-5-hydroxy-L-tryptophan ehlotshaniswa ne-eosinophilia-myalgia syndrome. UJ Rheumatol 1999; 26: 2714-7. Buka okungaqondakali.
  123. USinghal AB, uCaviness VS, uBegleiter AF, et al. I-vasoconstriction yeCerebral kanye nesifo sohlangothi ngemuva kokusebenzisa izidakamizwa ze-serotonergic. I-Neurology 2002; 58: 130-3. Buka okungaqondakali.
  124. U. S. Food and Drug Administration, Centre for Food Safety and Applied Nutrition, iHhovisi Lemikhiqizo Yezokudla, ilebula, kanye Nezithako Zokudla. Iphepha Lolwazi ku-L-Tryptophan ne-5-hydroxy-L-tryptophan, ngoFebhuwari 2001.
  125. UNardini M, uDe Stefano R, u-Iannuccelli M, et al. Ukwelashwa kokudangala nge-L-5-hydroxytryptophan kuhlanganiswe ne-chlorimipramine, isifundo esiyimpumputhe. I-Int J Clin Pharmacol Res 1983; 3: 239-50. Buka okungaqondakali.
  126. URibeiro CA. I-L-5-Hydroxytryptophan ku-prophylaxis yezinhlungu ezingapheli zohlobo lwekhanda: isifundo esilawulwa kabili, esingahleliwe, esilawulwa yi-placebo. Izinwele 2000; 40: 451-6. Buka okungaqondakali.
  127. I-Poldinger W, i-Calanchini B, i-Schwarz W. Indlela esebenzayo-yokwenza ukucindezeleka: ukuntuleka kwe-serotonin njenge-target syndrome uma kuqhathaniswa ne-5-hydroxytryptophan ne-fluvoxamine. I-Psychopathology 1991; 24: 53-81. Buka okungaqondakali.
  128. USternberg EM, uVan Woert MH, uSN osemncane, et al. Ukuthuthukiswa kwesifo esifana ne-scleroderma ngesikhathi sokwelapha i-L-5-hydroxytryptophan ne-carbidopa. N Engl J Med 1980; 303: 782-7. Buka okungaqondakali.
  129. Ukuphathwa Kwezokudla Nezidakamizwa zase-U.S. Ukungcola kuqinisekisiwe kokudla okungeziwe ku-5-hydroxy-L-tryptophan. Iphepha le-FDA Talk, Agasti 31, 1998; T98-48.
  130. UMeyer JS, uWelch KM, uDeshmukh VD, et al. I-Neurotransmitter eyandulela ama-amino acid ekwelapheni ukuwohloka komqondo okunama-infarct amaningi kanye nesifo i-Alzheimer's. UJ Amer Geriat Soc 1977; 25: 289-98. Buka okungaqondakali.
  131. I-Trouillas P, iBrudon F, i-Adeleine P. Ukuthuthukiswa kwe-cerebellar ataxia nefomu levorotatory ye-5-hydroxytryptophan: isifundo esiphindwe kabili esinokucutshungulwa kwedatha. I-Arch Neurol 1988; 45: 1217-22. Buka okungaqondakali.
  132. IKahn RS, iWestenberg HG. I-L-5-hydroxytryptophan ekwelapheni izinkinga zokukhathazeka. J Kuthinta Ukungezwani 1985; 8: 197-200. Buka okungaqondakali.
  133. UCangiano C, uCeci F, uCancino A, et al. Ukuziphatha kokuziphatha kanye nokunamathela emishinini yokudla kwizifundo zabantu abakhuluphele eziphathwe nge-5-hydroxytryptophan. Ngingu-J J Clin Nutrit 1992; 56: 863-7. Buka okungaqondakali.
  134. USarzi Puttini P, uCaruso I. Isifo se-fibromyalgia syndrome kanye ne-5-hydroxy-L-tryptophan: isifundo esivulekile sezinsuku ezingama-90. UJ Int Med Res 1992; 20: 182-9. Buka okungaqondakali.
  135. UNakajima T, Kudo Y, Kaneko Z.Ukuhlolwa kwemitholampilo kwe-5-hydroxy-L-tryptophan njengesidakamizwa sokulwa nokucindezelwa. UFolia Psychiatr Neurol Jpn 1978; 32: 223-30. Buka okungaqondakali.
  136. UMichelson D, Ikhasi le-SW, uCasey R, et al. Isifo esihlobene ne-eosinophilia-myalgia syndrome esihambisana nokuchayeka ku-L-5-hydroxytryptophan. UJ Rheumatol 1994; 21: 2261-5. Buka okungaqondakali.
  137. I-Birdsall TC. I-5-Hydroxytryptophan: Isiqalisi Somtholampilo Esisebenzayo Somtholampilo. I-Altern Med Rev 1998; 3: 271-80. Buka okungaqondakali.
Kugcine ukubuyekezwa - 12/29/2020

Ngokumangazayo

Umnikelo wamathambo (isiqu seseli)
Umuthi

Umnikelo wamathambo (isiqu seseli)

Umnkant ha wamathambo yizicubu ezithambile, ezinamafutha ngaphakathi kwamathambo akho. Umnkant ha wethambo unama- tem cell , okungama eli angavuthiwe aphenduka ama eli egazi. Abantu abanezifo ezi onge...
I-Telangiectasia
Umuthi

I-Telangiectasia

I-Telangiecta ia mincane, ikhuli e imithambo yegazi e ikhunjeni. Imvami a ayinabungozi, kepha ingahlot hani wa nezifo eziningana.I-Telangiecta ia ingahle ikhule noma kuphi ngaphakathi komzimba. Kepha ...